The US Food and Drug Administration (FDA) has approved a pill form of the weight-loss drug Wegovy, marking a significant milestone in obesity treatment, pharmaceutical company Novo Nordisk announced Monday.
The US Food and Drug Administration (FDA) has approved a pill form of the weight-loss drug Wegovy, marking a significant milestone in obesity treatment, pharmaceutical company Novo Nordisk announced Monday.
A booming appetite for weight-loss drugs among affluent Indians is transforming the country’s anti-obesity market, now valued at nearly $100 million — a sixfold surge in just five years. But